Check out your Company Bowl for anonymous work chats.
MD Anderson EGFR Classification licensed by BostonGene and Tempus to provide new insight on atypical mutations in lung cancer
BostonGene Showcases Comprehensive Approach to Precision Medicine at Immuno-Oncology 360°
BostonGene Announces Presentations at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition
BostonGene to Present at the 2022 San Antonio Breast Cancer Symposium
BostonGene Announces Abstract Presentation at the Association for Molecular Pathology 2022 Annual Meeting
BostonGene Announces Publication in Cell Reports Revealing Spatial Heterogeneity in the Tumor Microenvironment of Multiregional Clear Cell Renal Cell Carcinoma Biopsies
BostonGene Showcases Lifesaving Cancer Diagnostic and Treatment Recommendation Test at The 81st Annual Meeting of the Japanese Cancer Association
BostonGene Announces Strategic Alliance with the Massachusetts General Hospital Cancer Center
BostonGene Announces Publication in Cancer Cell Revealing the Development of a Machine Learning Cellular Deconvolution Algorithm that Accurately Reconstructs the Tumor Microenvironment and Supports Oncology Clinical Decision-making
BostonGene Announces Publication in Cancer Cell Revealing the Development of a Machine Learning Cellular Deconvolution Algorithm that Accurately Reconstructs the Tumor Microenvironment and Supports Oncology Clinical Decision-making
